Erratum to: Age-associated changes in the blood-brain barrier: comparative studies in human and mouse (Neuropathology and Applied Neurobiology, (2018), 44, 3, (328-340), 10.1111/nan.12408);Age-associated changes in the blood-brain barrier: comparative studies in human and mouse

Neuropathology and Applied Neurobiology

Volumn 44, Issue 3, 2018, Pages 328-340

  Goodall, E F ^a   Wang, C ^b   Simpson, J E ^a   Baker, D J ^a   Drew, D R ^a   Heath, P R ^a   Saffrey, M J ^b   Romero, I A ^b   Wharton, S B ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b OPEN UNIVERSITY   (United Kingdom)

Author keywords

Ageing; blood brain barrier; human; mouse

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; EVANS BLUE; FIBRINOGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; IBA1 PROTEIN; IMMUNOGLOBULIN G; PEPTIDES AND PROTEINS; PLASMA PROTEIN; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE 1; PROTEIN ZO1; UNCLASSIFIED DRUG; TJP1 PROTEIN, HUMAN;

ADULT; AGE; AGED; AGING; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BLOOD BRAIN BARRIER; BRAIN INJURY; BRAIN PERICYTE; BRAIN SIZE; CAPILLARY DENSITY; CELL DENSITY; CELL STRUCTURE; CEREBELLUM; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLIOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MIDDLE AGED; MOUSE; NEUROPATHOLOGY; NONHUMAN; OBSERVATIONAL STUDY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; YOUNG ADULT; ANIMAL; BRAIN; METABOLISM; PATHOLOGY; PERICYTE; TIGHT JUNCTION; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; BRAIN; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; PERICYTES; TIGHT JUNCTIONS; YOUNG ADULT; ZONULA OCCLUDENS-1 PROTEIN;

EID: 85019693826     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/nan.12515     Document Type: Erratum

References (45)

1. Aijaz S, Balda MS, Matter K. Tight junctions: molecular architecture and function. Int Rev Cytol 2006; 248: 261–98
2. Popescu BO, Toescu EC, Popescu LM, Bajenaru O, Muresanu DF, Schultzberg M, Bogdanovic N. Blood-brain barrier alterations in ageing and dementia. J Neurol Sci 2009; 283: 99–106
3. Haseloff RF, Dithmer S, Winkler L, Wolburg H, Blasig IE. Transmembrane proteins of the tight junctions at the blood-brain barrier: structural and functional aspects. Semin Cell Dev Biol 2015; 38: 16–25
4. Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol 1986; 103: 755–66
5. Chow BW, Gu C. The molecular constituents of the blood-brain barrier. Trends Neurosci 2015; 38: 598–608
6. Stanimirovic DB, Friedman A. Pathophysiology of the neurovascular unit: disease cause or consequence? J Cereb Blood Flow Metab 2012; 32: 1207–21
7. Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, Achim CL. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. The Am J Pathol 1999; 155: 1915–27
8. Kirk J, Plumb J, Mirakhur M, McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 2003; 201: 319–27
9. Nag S, Kapadia A, Stewart DJ. Review: molecular pathogenesis of blood-brain barrier breakdown in acute brain injury. Neuropathol Appl Neurobiol 2011; 37: 3–23
10. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008; 57: 178–201
11. Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 2008; 32: 200–19
12. Mooradian AD, McCuskey RS. In vivo microscopic studies of age-related changes in the structure and the reactivity of cerebral microvessels. Mech Ageing Dev 1992; 64: 247–54
13. Vorbrodt AW, Dobrogowska DH. Immunocytochemical evaluation of blood-brain barrier to endogenous albumin in adult, newborn and aged mice. Folia Histochem Cytobiol 1994; 32: 63–70
14. Mackic JB, Bading J, Ghiso J, Walker L, Wisniewski T, Frangione B, Zlokovic BV. Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions. Vascul Pharmacol 2002; 38: 303–13
15. Banks WA, Farr SA, Morley JE. Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse. J Gerontol A Biol Sci Med Sci 2000; 55: B601–6
16. Wadhwani KC, Koistinaho J, Balbo A, Rapoport SI. Blood-nerve and blood-brain barrier permeabilities and nerve vascular space in Fischer-344 rats of different ages. Mech Ageing Dev 1991; 58: 177–90
17. Janota CS, Brites D, Lemere CA, Brito MA. Glio-vascular changes during ageing in wild-type and Alzheimers disease-like APP/PS1 mice. Brain Res 2015; 1620: 153–68
18. Hosokawa M, Ueno M. Aging of blood-brain barrier and neuronal cells of eye and ear in SAM mice. Neurobiol Aging 1999; 20: 117–23
19. Hafezi-Moghadam A, Thomas KL, Wagner DD. ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage. Am J Physiol Cell Physiol 2007; 292: C1256–62
20. Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease–systematic review and meta-analysis. Neurobiol Aging 2009; 30: 337–52
21. Viggars AP, Wharton SB, Simpson JE, Matthews FE, Brayne C, Savva GM, Garwood C, Drew D, Shaw PJ, Ince PG. Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: a study in the MRC-CFAS population neuropathology cohort. Neurosci Lett 2011; 505: 25–30
22. Simpson JE, Wharton SB, Cooper J, Gelsthorpe C, Baxter L, Forster G, Shaw PJ, Savva G, Matthews FE, Brayne C, Ince PG. Alterations of the blood-brain barrier in cerebral white matter lesions in the ageing brain. Neurosci Lett 2010; 486: 246–51
23. Tavolato BF. Immunoglobulin G distribution in multiple sclerosis brain. An immunofluorescence study. J Neurol Sci 1975; 24: 1–11
24. Claudio L, Raine CS, Brosnan CF. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol 1995; 90: 228–38
25. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010; 8: e1000412
26. Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P. Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med 2009; 6: e1000180
27. Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001; 357: 169–75
28. Hicks P, Rolsten C, Brizzee D, Samorajski T. Age-related changes in rat brain capillaries. Neurobiol Aging 1983; 4: 69–75
29. Huber JD, VanGilder RL, Houser KA. Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. Am J Physiol Heart Circ Physiol 2006; 291: H2660–8
30. Elahy M, Jackaman C, Mamo JC, Lam V, Dhaliwal SS, Giles C, Nelson D, Takechi R. Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment. Immun Ageing 2015; 12: 2
31. Fischer S, Wobben M, Marti HH, Renz D, Schaper W. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res 2002; 63: 70–80
32. Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 2000; 20: 131–47
33. Naik P, Fofaria N, Prasad S, Sajja RK, Weksler B, Couraud PO, Romero IA, Cucullo L. Oxidative and pro-inflammatory impact of regular and denicotinized cigarettes on blood brain barrier endothelial cells: is smoking reduced or nicotine-free products really safe? BMC Neurosci 2014; 15: 51
34. Mamber C, Kamphuis W, Haring NL, Peprah N, Middeldorp J, Hol EM. GFAPdelta expression in glia of the developmental and adolescent mouse brain. PLoS ONE 2012; 7: e52659
35. Leech S, Kirk J, Plumb J, McQuaid S. Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis. Neuropathol Appl Neurobiol 2007; 33: 86–98
36. Iadecola C. Dangerous leaks: blood-brain barrier woes in the aging hippocampus. Neuron 2015; 85: 231–3
37. Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, Harrington MG, Chui HC, Law M, Zlokovic BV. Blood-brain barrier breakdown in the aging human hippocampus. Neuron 2015; 85: 296–302
38. Wharton SB, Simpson JE, Brayne C, Ince PG. Age-associated white matter lesions: the MRC Cognitive Function and Ageing Study. Brain Pathol 2015; 25: 35–43
39. Tomimoto H, Akiguchi I, Wakita H, Suenaga T, Nakamura S, Kimura J. Regressive changes of astroglia in white matter lesions in cerebrovascular disease and Alzheimer's disease patients. Acta Neuropathol 1997; 94: 146–52
40. Simpson JE, Fernando MS, Clark L, Ince PG, Matthews F, Forster G, O'Brien JT, Barber R, Kalaria RN, Brayne C, Shaw PJ, Lewis CE, Wharton SB. MRC CFAS Neuropathology Study Group. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol 2007; 33: 410–9
41. Chen A, Akinyemi RO, Hase Y, Firbank MJ. Ndung'u MN, Foster V, Craggs LJ, Washida K, Okamoto Y, Thomas AJ, Polvikoski TM, Allan LM, Oakley AE, O'Brien JT, Horsburgh K, Ihara M, Kalaria RN. Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia. Brain 2016; 139: 242–58
42. Ryu JK, Davalos D, Akassoglou K. Fibrinogen signal transduction in the nervous system. J Thromb Haemost 2009; 7(Suppl 1): 151–4
43. Brown WR, Thore CR. Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 2011; 37: 56–74
44. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 2010; 68: 409–27
45. Mori S, Sternberger NH, Herman MM, Sternberger LA. Leakage and neuronal uptake of serum protein in aged and Alzheimer brains. A postmortem phenomenon with antemortem etiology. Lab Invest 1991; 64: 345–51